Medical Management of Marfan Syndrome 54:54-57:10 So let's go go back to the take-home messages. What I would like to to convey is that there is now a very substantial evidence base for good medical treatment for patients with Marfan syndr…
Medical Management of Marfan Syndrome 53:29-54:53 This is a bit more controversial perhaps. There are a group of medications called triptans. These are used for migraine and usually used as, as an acute treatment. They're not used for prev…
Medical Management of Marfan Syndrome 52:14-53:28 The, the next thing I want to bring to your attention is that there are medications called calcium channel blockers. These are medications like verapamil, diltiazem, things like that. They'…
Medical Management of Marfan Syndrome 48:55-52:09 I'm going to just talk about a couple of other issues now. There is and the, in particular I want to talk about the medications that we should not be giving and I'm sorry I'm running a bit …
Medical Management of Marfan Syndrome 48:17-48:54 So I'm now going to just skip forward and just draw some conclusions from the trials. So angiotensin receptor blockers reduce the rate of aortic growth in Marfan syndrome. The effects of AR…
Medical Management of Marfan Syndrome 44:21-48:07 I'm just going to go back and say that we were able to explore, you know, one of the questions was, you know, was there evidence that these medications reduced the rate of tearing of the ao…
Medical Management of Marfan Syndrome 42:43-44:20 And then, we, then went on to look at trials where they had compared angiotensin receptor blockers with beta blockers. This is a different kind of trial. ARB versus beta blockers head-to-he…
Medical Management of Marfan Syndrome 40:34-42:42 I think one, there a couple of things that I think, are important that is I need to emphasize that when we looked specifically at beta blockers we found that patients with beta blockers had…
Medical Management of Marfan Syndrome 28:25-40:30 So a number of trials now were, were, were then undertaken and we then organized with the, with the investigators who, who did these trials. We put these trials all together to try to give …
Medical Management of Marfan Syndrome 23:42-28:24 So I want to talk now about the two different classes of medications and we're going to dig into this in a lot of detail and people are asking really sensible questions in the Q&A and I'm g…
Medical Management of Marfan Syndrome 15:58-23:40 So, so next I just want to change topic before we come on to the, the, the, the real substance of what I want to talk about but I just want to make sure everyone's on the same page with und…
Medical Management of Marfan Syndrome 10:18-15:56 So what, what issue am I trying to resolve now? Marfan syndrome obviously is a multisystem disorder. It affects the eyes, it affects the spine, it affects the muscular-skeletal system. In f…
Medical Management of Marfan Syndrome 5:35-10:18 So I've been asked to talk about the, thankfully, the area that I know most about, which is what, what I think of is the medical treatment of Marfan syndrome. What, what do I mean by medical…
2024年2月9日 カレン・ブルックス 謎の診断 未知との戦い 喪失と学び 調査と希望 意義ある目的 私は生まれた時にマルファン症候群と診断されました。突然変異による発症だった父から、4人きょうだいのうちの2人がマルファンを受け継ぎました。今年の夏で82歳…
Surgery for Sporadic Aortic Aneurysms of the Aortic Root and Ascending Aorta On behalf of the GenTAC alliance I'll be speaking on surgery for sporadic aneurysms of the aortic root and ascending aorta. My name is Chris Malaisrie. I'm a card…
遺伝子検査の結果を読み解き、マルファン症候群やロイス・ディーツ症候群、血管型エーラス・ダンロス症候群といった疾患であるかどうかを診断することは、困難な場合もあります。そこで、検査結果の意味や次に検討すべきステップを理解をしやすくするための…
遺伝子検査の結果を読み解き、マルファン症候群やロイス・ディーツ症候群、血管型エーラス・ダンロス症候群といった疾患であるかどうかを診断することは、困難な場合もあります。そこで、検査結果の意味や次に検討すべきステップを理解をしやすくするための…
Surgical Thresholds for Root and Ascending Aortic Replacement in Loeys- Dietz Syndrome Hi, I'm Alan Braverman. I'm the director of the Marfan syndrome and aortopathy center at Washington University in St Louis school of medicine and on beh…
Surgical Thresholds for Root and Ascending Aortic Replacement in Loeys- Dietz Syndrome Hi, I'm Alan Braverman. I'm the director of the Marfan syndrome and aortopathy center at Washington University in St Louis school of medicine and on beh…
Medical Therapy in Marfan Syndrome: Update from ACC/AHA Guidelines Hi, I'm Alan Braverman from Washington University in St Louis School of Medicine, Barnes Jewish Hospital. Today it's my pleasure to provide information on medical therapy i…
1. はじめに マルファン症候群とは マルファン症候群の特徴 マルファン症候群の原因 マルファン症候群の発症率 マルファン症候群の診断 マルファン症候群患者の人生 マルファン症候群において急を要する疾患 マルファン症候群の類縁疾患 2. 検査が必要な生徒…
AHA/ACC Aortic Disease Guidelines: Delivery 0:00-3:43 Hello, my name is Mary Shepard from the University of Kentucky and it is my pleasure to be here today to talk with you about delivery and people who have aortic disease. ケンタッキー大…
ACC Aortic Disease Guidelines: Pregnancy 5:53-6:34 To end some words about medication during pregnancy, so it is recommended that women take beta blockers throughout pregnancy and as contra-indicated this should be based on a shared decisi…
ACC Aortic Disease Guidelines: Pregnancy 4:02-5:52 Regarding cardiovascular counseling so as I mentioned this is important for, the for, the ladies, it, they should be informed that the risk for aortic dissection increases during pregnancy…
ACC Aortic Disease Guidelines: Pregnancy 0:00-4:02 Hello, my name is Julie De Backer. I am a cardiologist and clinical geneticist working at the Ghent University Hospital in Belgium and it is my pleasure to present to you today the topic o…
2023年12月12日 The Marfan Foundation デブラ・シーンさんは、娘、患者、母親、祖母の立場でマルファン症候群と向き合ってきました。マルファン症候群を知るきっかけとなったのは、年を重ねた父親の大動脈に見つかった複数の病変でした。これにより父親にマ…
Pediatric Activity Guidelines - HTAAD 5:01-8:43 So in general when we are restricting individuals from activity that is to help them to avoid an aortic event or perhaps disease progression we know aortic dissection is a very rare event. In…
Pediatric Activity Guidelines - HTAAD 1:30-5:00 Why should we be active? Originally the goal was survival so, you know, several decades ago really the main goal was trying to get people to be able to live long because the mortality rates w…
Pediatric Activity Guidelines - HTAAD 0:00-1:29 Hi, I'm Dr. Glenn Ianucci, a pediatric cardiologist at children's health care of Atlanta and director of the aorta and vascular clinic there and on behalf of the GenTAC alliance I'll be prese…
Medical Therapy in the Pediatric Patient 4:53-7:40 So in many cases families will say, "Well, if my aorta is not enlarged now or not substantially enlarge now then why do I need to take medication?" So when approaching this discussion with…
